Jiuzhoutong Pharmaceutical Group Co., Ltd.
Jiuzhoutong Pharmaceutical Group Co., Ltd. is a large enterprise group with wholesale, retail chains, pharmaceutical production and R&D and related value-added services as its core business. As of December 31, 2012, Jiuzhoutong Pharmaceutical Group has total assets of 14.804 billion yuan, 9,148 employees, more than 80 subsidiaries, and 875 retail chain pharmacies directly and franchise. In 2012, Jiuzhoutong Pharmaceutical Group achieved operating income of 29.508 billion yuan and paid nearly 500 million yuan in taxes. Jiuzhoutong Pharmaceutical Group has a complete variety structure and rich customer resources, with more than 160,000 business specifications, 5,600 upstream suppliers and more than 70,000 downstream customers, and has obtained national or regional general distribution or general agent qualifications for 131 domestic drugs. So far, Jiuzhoutong Pharmaceutical Group has established 22 provincial subsidiaries (large pharmaceutical flow centers) in 22 provincial capital cities across the country, 29 prefecture-level companies (regional pharmaceutical flow distribution centers) and more than 400 terminal distribution points in 29 prefecture-level cities, forming a logistics distribution network covering most county-level administrative regions across the country. To build the core competitiveness of the enterprise, Jiuzhoutong Pharmaceutical Group adheres to the concept of "technology makes service more outstanding" and is committed to the development and application of modern logistics technology and information technology. At present, Jiuzhoutong Pharmaceutical Group is the only pharmaceutical distribution company in China that has independent integrated logistics planning, logistics implementation, and system integration capabilities. It has obtained more than 20 independent intellectual property rights and is in a leading and internationally first-class position in modern logistics technology and information technology. It is the only company in the domestic pharmaceutical industry that has won the title of "China's 30 Years of Flag Enterprise for Logistics Reform and Opening Up in 30 Years". Jiuzhoutong Pharmaceutical Group has the ability to provide demand solutions and value-added services to upstream and downstream customers, and has gradually extended technology value-added services to the upstream and downstream industrial chains, forming three unique product lines: logistics management, supply chain management, and hospital management, which can meet customers' highest technology requirements. In recent years, Jiuzhoutong Pharmaceutical Group has won many honors such as "National 5A-level Logistics Enterprise", "Hubei Province's Most Influential Private Enterprise", "Hubei Province's Contract-abiding and Credit-oriented Enterprise", "China's Excellent Enterprise for Social Responsibility", and "National Non-public Enterprises' Double Strong Top 100 Party Organizations". In the future, Jiuzhoutong Pharmaceutical Group will adapt to the changes in the pharmaceutical market, continue to adhere to the core business of pharmaceutical distribution, hospital pure sales, traditional Chinese medicinal materials, medical devices, retail chains as strategic businesses, and logistics technology marketing, e-commerce, international trade, raw materials, etc. as the business portfolio strategy; expand and improve the layout of the pharmaceutical marketing network, continuously provide cost-effective services for the pharmaceutical and health industry, and strive to build Jiuzhoutong into the best service provider of China's pharmaceutical and health industry.
Jiuzhoutong Pharmaceutical Group Co., Ltd.
Jiuzhoutong Pharmaceutical Group Co., Ltd. is a large enterprise group with wholesale, retail chains, pharmaceutical production and R&D and related value-added services as its core business. As of December 31, 2012, Jiuzhoutong Pharmaceutical Group has total assets of 14.804 billion yuan, 9,148 employees, more than 80 subsidiaries, and 875 retail chain pharmacies directly and franchise. In 2012, Jiuzhoutong Pharmaceutical Group achieved operating income of 29.508 billion yuan and paid nearly 500 million yuan in taxes. Jiuzhoutong Pharmaceutical Group has a complete variety structure and rich customer resources, with more than 160,000 business specifications, 5,600 upstream suppliers and more than 70,000 downstream customers, and has obtained national or regional general distribution or general agent qualifications for 131 domestic drugs. So far, Jiuzhoutong Pharmaceutical Group has established 22 provincial subsidiaries (large pharmaceutical flow centers) in 22 provincial capital cities across the country, 29 prefecture-level companies (regional pharmaceutical flow distribution centers) and more than 400 terminal distribution points in 29 prefecture-level cities, forming a logistics distribution network covering most county-level administrative regions across the country. To build the core competitiveness of the enterprise, Jiuzhoutong Pharmaceutical Group adheres to the concept of "technology makes service more outstanding" and is committed to the development and application of modern logistics technology and information technology. At present, Jiuzhoutong Pharmaceutical Group is the only pharmaceutical distribution company in China that has independent integrated logistics planning, logistics implementation, and system integration capabilities. It has obtained more than 20 independent intellectual property rights and is in a leading and internationally first-class position in modern logistics technology and information technology. It is the only company in the domestic pharmaceutical industry that has won the title of "China's 30 Years of Flag Enterprise for Logistics Reform and Opening Up in 30 Years". Jiuzhoutong Pharmaceutical Group has the ability to provide demand solutions and value-added services to upstream and downstream customers, and has gradually extended technology value-added services to the upstream and downstream industrial chains, forming three unique product lines: logistics management, supply chain management, and hospital management, which can meet customers' highest technology requirements. In recent years, Jiuzhoutong Pharmaceutical Group has won many honors such as "National 5A-level Logistics Enterprise", "Hubei Province's Most Influential Private Enterprise", "Hubei Province's Contract-abiding and Credit-oriented Enterprise", "China's Excellent Enterprise for Social Responsibility", and "National Non-public Enterprises' Double Strong Top 100 Party Organizations". In the future, Jiuzhoutong Pharmaceutical Group will adapt to the changes in the pharmaceutical market, continue to adhere to the core business of pharmaceutical distribution, hospital pure sales, traditional Chinese medicinal materials, medical devices, retail chains as strategic businesses, and logistics technology marketing, e-commerce, international trade, raw materials, etc. as the business portfolio strategy; expand and improve the layout of the pharmaceutical marketing network, continuously provide cost-effective services for the pharmaceutical and health industry, and strive to build Jiuzhoutong into the best service provider of China's pharmaceutical and health industry.
Sunflower Pharmaceutical Group Co., Ltd.
Kuihua Pharmaceutical Group is a large private pharmaceutical enterprise group that focuses on Chinese patent medicines, supplemented by chemical drugs, biological drugs, and supplementary health products, integrating drug manufacturing, marketing and scientific research. It now has 12 pharmaceutical companies, including Wuchang Sunflower, Yichun Sunflower, Jiamusi Sunflower, Tangshan Sunflower, Hengshui Sunflower, Yizhou Sunflower, Chongqing Sunflower, Longzhong Sunflower, Wudang Sunflower, Linjiang Sunflower, Guizhou Sunflower, etc., and 4 pharmaceutical companies.
Sunflower Pharmaceutical Group Co., Ltd.
Kuihua Pharmaceutical Group is a large private pharmaceutical enterprise group that focuses on Chinese patent medicines, supplemented by chemical drugs, biological drugs, and supplementary health products, integrating drug manufacturing, marketing and scientific research. It now has 12 pharmaceutical companies, including Wuchang Sunflower, Yichun Sunflower, Jiamusi Sunflower, Tangshan Sunflower, Hengshui Sunflower, Yizhou Sunflower, Chongqing Sunflower, Longzhong Sunflower, Wudang Sunflower, Linjiang Sunflower, Guizhou Sunflower, etc., and 4 pharmaceutical companies.
Yantai Traditional Chinese Medicine Heritage Pharmacy Chain Co., Ltd.
The brand of Traditional Chinese Medicine Shijia Pharmacy was established in 2005 and is affiliated to Yantai Traditional Chinese Medicine Shijia Pharmaceutical Chain Co., Ltd., Gao Pingpai is a chain pharmacy focusing on providing high-quality medical services to customers and friends. The brand insists on "let the people spend the least money and buy the most effective medicine."
Yantai Traditional Chinese Medicine Heritage Pharmacy Chain Co., Ltd.
The brand of Traditional Chinese Medicine Shijia Pharmacy was established in 2005 and is affiliated to Yantai Traditional Chinese Medicine Shijia Pharmaceutical Chain Co., Ltd., Gao Pingpai is a chain pharmacy focusing on providing high-quality medical services to customers and friends. The brand insists on "let the people spend the least money and buy the most effective medicine."
Beijing Kaierkang Pharmacy Co., Ltd.
Beijing Kaierkang Pharmacy Co., Ltd. is located at No. 26, Dahongmen West Road, Fengtai District, Beijing. The company adheres to the scientific outlook on development to take the overall situation, implements the development strategy of talent as the foundation, market as the oriented, efficiency as the core, innovation as the driving force, and professional brand building, and firmly takes the road of rapid, coordinated, sustainable and healthy development. Behind a series of fruits is the hard sweat and the joy of success. Integrity, practicality, diligence and innovation are our corporate spirit. Make the company stronger in order to repay the country, society, users, shareholders, and employees, and contribute your own strength to the civilization of society and the progress of mankind!
Beijing Kaierkang Pharmacy Co., Ltd.
Beijing Kaierkang Pharmacy Co., Ltd. is located at No. 26, Dahongmen West Road, Fengtai District, Beijing. The company adheres to the scientific outlook on development to take the overall situation, implements the development strategy of talent as the foundation, market as the oriented, efficiency as the core, innovation as the driving force, and professional brand building, and firmly takes the road of rapid, coordinated, sustainable and healthy development. Behind a series of fruits is the hard sweat and the joy of success. Integrity, practicality, diligence and innovation are our corporate spirit. Make the company stronger in order to repay the country, society, users, shareholders, and employees, and contribute your own strength to the civilization of society and the progress of mankind!
Liuzhou Guizhongda Pharmacy Chain Co., Ltd.
Liuzhou Guizhong Pharmacy Chain Co., Ltd. was established in September 2001. It is a wholly-owned subsidiary of Guangxi Liuzhou Pharmaceutical Co., Ltd. (a larger pharmaceutical wholesale enterprise in Guangxi). It is a pharmaceutical retail enterprise with a wide range of pharmaceutical business categories and a wide variety of varieties in Liuzhou. The company passed the GSP certification in August 2003 and is the first pharmaceutical retail enterprise in Liuzhou to pass the GSP certification earlier. The company currently has 240 direct chain stores, with outlets distributed in most cities and cities in Guangxi, with 1,200 employees. The company adopts the "eight unified" chain management model and adheres to the principle of "standardized management and legal management". To date, the sales scale has increased from 20 million at the beginning of its establishment to 710 million yuan in 2016. In order to better serve the people and the society, the company will strive to make the company bigger and stronger, and actively expand into the entire region, so as to truly become the brand of Guangxi pharmaceutical retail pharmacies.
Liuzhou Guizhongda Pharmacy Chain Co., Ltd.
Liuzhou Guizhong Pharmacy Chain Co., Ltd. was established in September 2001. It is a wholly-owned subsidiary of Guangxi Liuzhou Pharmaceutical Co., Ltd. (a larger pharmaceutical wholesale enterprise in Guangxi). It is a pharmaceutical retail enterprise with a wide range of pharmaceutical business categories and a wide variety of varieties in Liuzhou. The company passed the GSP certification in August 2003 and is the first pharmaceutical retail enterprise in Liuzhou to pass the GSP certification earlier. The company currently has 240 direct chain stores, with outlets distributed in most cities and cities in Guangxi, with 1,200 employees. The company adopts the "eight unified" chain management model and adheres to the principle of "standardized management and legal management". To date, the sales scale has increased from 20 million at the beginning of its establishment to 710 million yuan in 2016. In order to better serve the people and the society, the company will strive to make the company bigger and stronger, and actively expand into the entire region, so as to truly become the brand of Guangxi pharmaceutical retail pharmacies.
Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
Founded in 1956, it integrates rubber ointment, gel agent, oral liquid scientific research, production and sales. Its Musk Wind Bleeding Ointment, Shennong Analgesic Ointment, Lianbai Burn Ointment, etc. are more famous in the industry. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. was founded in 1956. The company currently has 23 varieties of five dosage forms: rubber ointment, ointment, gel, cream, and oral liquid. All dosage forms have passed the national new version of GMP certification. They are a pharmaceutical company with a history of more than 50 years and integrating production, sales and scientific research. In 2009, the company's Musk Wind Bleeding Ointment, Shennong Analgesic Ointment and Lianbai Burn Ointment were all included in the "National Medical Insurance Drug Catalogue". "Taking technology as the leader and managing to generate benefits" is an inevitable requirement for the survival and development of Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. In order to maintain the sustainable development of the enterprise and enhance the vitality of the enterprise, Jiminren will inherit the foundation of 50 years, continue to strengthen and improve the enterprise, and make new contributions to the healthy civilization of mankind.
Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
Founded in 1956, it integrates rubber ointment, gel agent, oral liquid scientific research, production and sales. Its Musk Wind Bleeding Ointment, Shennong Analgesic Ointment, Lianbai Burn Ointment, etc. are more famous in the industry. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. was founded in 1956. The company currently has 23 varieties of five dosage forms: rubber ointment, ointment, gel, cream, and oral liquid. All dosage forms have passed the national new version of GMP certification. They are a pharmaceutical company with a history of more than 50 years and integrating production, sales and scientific research. In 2009, the company's Musk Wind Bleeding Ointment, Shennong Analgesic Ointment and Lianbai Burn Ointment were all included in the "National Medical Insurance Drug Catalogue". "Taking technology as the leader and managing to generate benefits" is an inevitable requirement for the survival and development of Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. In order to maintain the sustainable development of the enterprise and enhance the vitality of the enterprise, Jiminren will inherit the foundation of 50 years, continue to strengthen and improve the enterprise, and make new contributions to the healthy civilization of mankind.
Guangzhou Baozhilin Pharmacy Chain Co., Ltd.
Guangzhou Baozhilin Pharmacy Chain Co., Ltd. (Guangzhou Baozhilin Pharmacy) was established on October 3, 2000. It is located at No. 10, Zhixin South Road, Yuexiu District, the center of Guangzhou. It is in front of it. It is the First Affiliated Hospital of Sun Yat-sen Medical University and the Dongshankou Telecom Building is behind it. After several years of steady development and resource integration, our company currently has wholesale companies and 10 retail stores, of which 9 branches have obtained the qualification of "Guangzhou Urban Employee Social Medical Insurance Designated Retail Pharmacy". The company has developed into a modern enterprise integrating retail and wholesale of pharmaceutical products. It has specialized in operating anti-tumor drugs, liver disease drugs, cardiovascular drugs, diabetes drugs, other new and special drugs, traditional Chinese medicine agents and ginseng and antler supplements. It has now become a highly reputable and trustworthy enterprise in Guangzhou. At the same time, it has established good cooperative relationships with many domestic and foreign pharmaceutical companies and pharmaceutical wholesale companies, and can contact cutting-edge scarce drugs, purchase supplies in a timely manner, and provide product research and development and treatment information. At present, our company operates more than 5,000 kinds of specialized drugs, of which more than 1,000 varieties of anti-tumor drugs are operated at home and abroad alone.
Guangzhou Baozhilin Pharmacy Chain Co., Ltd.
Guangzhou Baozhilin Pharmacy Chain Co., Ltd. (Guangzhou Baozhilin Pharmacy) was established on October 3, 2000. It is located at No. 10, Zhixin South Road, Yuexiu District, the center of Guangzhou. It is in front of it. It is the First Affiliated Hospital of Sun Yat-sen Medical University and the Dongshankou Telecom Building is behind it. After several years of steady development and resource integration, our company currently has wholesale companies and 10 retail stores, of which 9 branches have obtained the qualification of "Guangzhou Urban Employee Social Medical Insurance Designated Retail Pharmacy". The company has developed into a modern enterprise integrating retail and wholesale of pharmaceutical products. It has specialized in operating anti-tumor drugs, liver disease drugs, cardiovascular drugs, diabetes drugs, other new and special drugs, traditional Chinese medicine agents and ginseng and antler supplements. It has now become a highly reputable and trustworthy enterprise in Guangzhou. At the same time, it has established good cooperative relationships with many domestic and foreign pharmaceutical companies and pharmaceutical wholesale companies, and can contact cutting-edge scarce drugs, purchase supplies in a timely manner, and provide product research and development and treatment information. At present, our company operates more than 5,000 kinds of specialized drugs, of which more than 1,000 varieties of anti-tumor drugs are operated at home and abroad alone.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Pharmaceutical Co., Ltd. was established in 1973. In November 1992, with the approval of the Guangzhou Municipal People's Government, five other companies including Guangzhou Baiyunshan Pharmaceutical Factory were restructured and established joint-stock enterprises. In November 1993, it was listed on the Shenzhen Stock Exchange as one of the first listed companies in Guangzhou, and now has a total share capital of 469 million yuan. In 2007, the sales scale reached 3.61 billion yuan, and in 2008, the sales scale exceeded 4 billion yuan. The company has been committed to brand building for many years and is one of the first companies to establish a pharmaceutical preparation brand in China. Its brand popularity and reputation have a strong influence among consumers across the country. In 2006, the "Baiyunshan" trademark was recognized as a well-known trademark in China, and in 2007, it was identified as the title of "a famous export brand in Guangdong Province that focuses on cultivating and developing". In 2008, the brand value was evaluated as 10.52 billion yuan. In terms of network construction, the company took the lead in establishing its own marketing network across the country more than 30 years ago with the courage to be the first in the world. It has now formed a marketing network driven by its headquarters and radiated across the country and Asia and Africa. In terms of scientific and technological innovation, the company implements the "Science and Technology Baiyun Mountain" strategy, cooperates with first-class scientific research institutions, well-known domestic research institutions, and international antibiotic giants to develop drugs with world-class advanced levels. Currently, it has more than 1,700 drug approval documents, and dozens of varieties have a leading position in the national pharmaceutical industry. Among them, the development and production and launch of Xianlisu (cephalothamidine) powder injection has filled a gap in my country's self-development and development of cephalosporin antibiotics, and won the second prize of the National Technical Invention in 2007. The company established the first modern Chinese medicine research institute in South China led by Academician Liu Changxiao. The institute was approved by the state as a postdoctoral workstation; it established the "Traditional Medicine Prevention and Treatment of Viral Infectious Diseases" led by five academicians including Zhong Nanshan. This is the first cross-field industry-university-research consortium produced in my country's traditional Chinese medicine community, forming a national, provincial and municipal science and technology research and development system. The company has always adhered to the business philosophy of "love fills the world", is brave enough to assume social responsibilities, and takes care of health and dedicate love as its responsibility. Since its founding, it has always cared for the disadvantaged groups in society and pursued the cause of life and health tirelessly. Great love is shown in the face of major disasters, from the early Daxinganling fire and 98 floods to the recent SARS, the southern ice and snow disaster, the Wenchuan earthquake, etc., we actively donate money and medicine to fight the disaster; in order to inherit the culture of traditional Chinese medicine, the "Shennong Caotang" Traditional Chinese Medicine Museum was established; the company strives to build "Responsible Baiyun Mountain and Citizen Baiyun Mountain", pioneering the "family expired drug recycling mechanism", "five-level quality system", and advocating "rational use of medicines"; striving to promote energy conservation and emission reduction, environmental protection and safe production, and has won many honors such as "National Contract-Based Trust-Breaking" and Guangdong Province's "Clean Production Enterprise", "Water-saving Enterprise", "Safety Culture Demonstration Unit", and "Customer Satisfied Service Celebrity Enterprise". In the future, the company will make stability with professionalism, do a good job in scientific management, become stronger with scientific innovation, and become bigger with capital operation. Baiyunshan Pharmaceutical will build a first-class brand enterprise with high technology content, high cultural added value, high market share and strong competitiveness.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Pharmaceutical Co., Ltd. was established in 1973. In November 1992, with the approval of the Guangzhou Municipal People's Government, five other companies including Guangzhou Baiyunshan Pharmaceutical Factory were restructured and established joint-stock enterprises. In November 1993, it was listed on the Shenzhen Stock Exchange as one of the first listed companies in Guangzhou, and now has a total share capital of 469 million yuan. In 2007, the sales scale reached 3.61 billion yuan, and in 2008, the sales scale exceeded 4 billion yuan. The company has been committed to brand building for many years and is one of the first companies to establish a pharmaceutical preparation brand in China. Its brand popularity and reputation have a strong influence among consumers across the country. In 2006, the "Baiyunshan" trademark was recognized as a well-known trademark in China, and in 2007, it was identified as the title of "a famous export brand in Guangdong Province that focuses on cultivating and developing". In 2008, the brand value was evaluated as 10.52 billion yuan. In terms of network construction, the company took the lead in establishing its own marketing network across the country more than 30 years ago with the courage to be the first in the world. It has now formed a marketing network driven by its headquarters and radiated across the country and Asia and Africa. In terms of scientific and technological innovation, the company implements the "Science and Technology Baiyun Mountain" strategy, cooperates with first-class scientific research institutions, well-known domestic research institutions, and international antibiotic giants to develop drugs with world-class advanced levels. Currently, it has more than 1,700 drug approval documents, and dozens of varieties have a leading position in the national pharmaceutical industry. Among them, the development and production and launch of Xianlisu (cephalothamidine) powder injection has filled a gap in my country's self-development and development of cephalosporin antibiotics, and won the second prize of the National Technical Invention in 2007. The company established the first modern Chinese medicine research institute in South China led by Academician Liu Changxiao. The institute was approved by the state as a postdoctoral workstation; it established the "Traditional Medicine Prevention and Treatment of Viral Infectious Diseases" led by five academicians including Zhong Nanshan. This is the first cross-field industry-university-research consortium produced in my country's traditional Chinese medicine community, forming a national, provincial and municipal science and technology research and development system. The company has always adhered to the business philosophy of "love fills the world", is brave enough to assume social responsibilities, and takes care of health and dedicate love as its responsibility. Since its founding, it has always cared for the disadvantaged groups in society and pursued the cause of life and health tirelessly. Great love is shown in the face of major disasters, from the early Daxinganling fire and 98 floods to the recent SARS, the southern ice and snow disaster, the Wenchuan earthquake, etc., we actively donate money and medicine to fight the disaster; in order to inherit the culture of traditional Chinese medicine, the "Shennong Caotang" Traditional Chinese Medicine Museum was established; the company strives to build "Responsible Baiyun Mountain and Citizen Baiyun Mountain", pioneering the "family expired drug recycling mechanism", "five-level quality system", and advocating "rational use of medicines"; striving to promote energy conservation and emission reduction, environmental protection and safe production, and has won many honors such as "National Contract-Based Trust-Breaking" and Guangdong Province's "Clean Production Enterprise", "Water-saving Enterprise", "Safety Culture Demonstration Unit", and "Customer Satisfied Service Celebrity Enterprise". In the future, the company will make stability with professionalism, do a good job in scientific management, become stronger with scientific innovation, and become bigger with capital operation. Baiyunshan Pharmaceutical will build a first-class brand enterprise with high technology content, high cultural added value, high market share and strong competitiveness.
Zhejiang Yunkaiyamei Pharmacy Chain Co., Ltd.
Zhejiang Yunkai Yamei Pharmacy Chain Co., Ltd. (hereinafter referred to as Yunkai Yamei Pharmacy) was established in November 2011 with a registered capital of 50 million yuan. It was jointly invested and established by Zhejiang Haizheng Pharmaceutical Co., Ltd. (stock code 600267), Shanghai Jiangeng Pharmaceutical Technology Co., Ltd., and Shanghai Yingyi Culture Communication Co., Ltd. (a wholly-owned subsidiary of Yingyi Group). In December 2015, Yunkai Asia and America completed a RMB 100 million Series A financing led by Northern Lights and followed by Huagai Capital.
Zhejiang Yunkaiyamei Pharmacy Chain Co., Ltd.
Zhejiang Yunkai Yamei Pharmacy Chain Co., Ltd. (hereinafter referred to as Yunkai Yamei Pharmacy) was established in November 2011 with a registered capital of 50 million yuan. It was jointly invested and established by Zhejiang Haizheng Pharmaceutical Co., Ltd. (stock code 600267), Shanghai Jiangeng Pharmaceutical Technology Co., Ltd., and Shanghai Yingyi Culture Communication Co., Ltd. (a wholly-owned subsidiary of Yingyi Group). In December 2015, Yunkai Asia and America completed a RMB 100 million Series A financing led by Northern Lights and followed by Huagai Capital.
Beijing Tongrentang (Group) Co., Ltd.
China Beijing Tongrentang (Group) Co., Ltd. is a wholly state-owned company authorized by the municipal government to operate state-owned assets. Tongrentang was founded in 1669 and has a history of more than 300 years. Beijing Tongrentang has always adhered to the development strategy of "taking modern Chinese medicine as the core, developing life and health industries, and becoming an internationally renowned modern Chinese medicine group", taking the policy of "longer, stronger, and bigger", leading with innovation and developing enterprises with technology As its own mission, it has formed three major sectors: modern pharmaceutical industry, retail commerce and medical services, and has built an enterprise structure of six secondary groups, three hospitals and two reserve units. It currently has three listed companies. The group has more than 1,500 products including medicines, hospital preparations, health foods, foods, cosmetics, etc., 28 production bases, 83 modern production lines, a national engineering center and a postdoctoral research workstation. Since 1997, Tongrentang has maintained sustained and healthy development, and its economic indicators have maintained double-digit growth for 15 consecutive years, doubling every five years. As of 2011, the group had a total assets of 14 billion yuan, sales revenue of 16.3 billion yuan, profit of 1.316 billion yuan, export revenue of 33.92 million US dollars, and opened 64 pharmacies and 1 overseas production and R&D base in 16 overseas countries and regions. Products Sales to more than 40 countries and regions overseas. With the rapid development of Tongrentang, the brand maintenance and improvement, the innovation and inheritance of culture have also achieved fruitful results. "Tongrentang Traditional Chinese Medicine Culture" has been included in the first batch of national intangible cultural heritage list. Tongrentang is both an economic entity and a culture. The dual functions of carriers are becoming increasingly apparent.
Beijing Tongrentang (Group) Co., Ltd.
China Beijing Tongrentang (Group) Co., Ltd. is a wholly state-owned company authorized by the municipal government to operate state-owned assets. Tongrentang was founded in 1669 and has a history of more than 300 years. Beijing Tongrentang has always adhered to the development strategy of "taking modern Chinese medicine as the core, developing life and health industries, and becoming an internationally renowned modern Chinese medicine group", taking the policy of "longer, stronger, and bigger", leading with innovation and developing enterprises with technology As its own mission, it has formed three major sectors: modern pharmaceutical industry, retail commerce and medical services, and has built an enterprise structure of six secondary groups, three hospitals and two reserve units. It currently has three listed companies. The group has more than 1,500 products including medicines, hospital preparations, health foods, foods, cosmetics, etc., 28 production bases, 83 modern production lines, a national engineering center and a postdoctoral research workstation. Since 1997, Tongrentang has maintained sustained and healthy development, and its economic indicators have maintained double-digit growth for 15 consecutive years, doubling every five years. As of 2011, the group had a total assets of 14 billion yuan, sales revenue of 16.3 billion yuan, profit of 1.316 billion yuan, export revenue of 33.92 million US dollars, and opened 64 pharmacies and 1 overseas production and R&D base in 16 overseas countries and regions. Products Sales to more than 40 countries and regions overseas. With the rapid development of Tongrentang, the brand maintenance and improvement, the innovation and inheritance of culture have also achieved fruitful results. "Tongrentang Traditional Chinese Medicine Culture" has been included in the first batch of national intangible cultural heritage list. Tongrentang is both an economic entity and a culture. The dual functions of carriers are becoming increasingly apparent.
Zhende Medical was founded in 1993. It is a large enterprise specializing in the research and development, production and sales of medical dressing series products, and a standard drafting unit for the varicose vein socks. Zhende Medical is an enterprise integrating R&D, production and sales. The group involves traditional medical dressings, pressure treatment and fixation, modern wound care, surgical infection management, incontinence care products, automation equipment and other industries. Products are sold in more than 70 countries and regions. Europe is the core area of the international market. More than 3,000 medical institutions are using Zhende's products in more than 30 provinces and cities in China. Since the start of Zhende in Shaoxing, Zhende Medical has experienced 20 years of development. Zhende Medical adheres to the corporate spirit of "responsibility, learning, dedication and integrity", based on the development of its main business, builds core competitiveness, and takes "brand, innovation, and professionalism" In order to achieve business philosophy, we will seize the historical opportunities of the development of China's disposable medical consumables market demand, accelerate industrial integration and product research and development and innovation, increase R&D investment, market channel construction and talent construction, realize the strategic transformation of the enterprise industry, and improve the core competitiveness of the enterprise. Zhende Medical is gathering more strength to promote the sustainable development of the company through technological innovation and business model innovation.
ZHENDE MEDICAL INC.
Zhende Medical was founded in 1993. It is a large enterprise specializing in the research and development, production and sales of medical dressing series products, and a standard drafting unit for the varicose vein socks. Zhende Medical is an enterprise integrating R&D, production and sales. The group involves traditional medical dressings, pressure treatment and fixation, modern wound care, surgical infection management, incontinence care products, automation equipment and other industries. Products are sold in more than 70 countries and regions. Europe is the core area of the international market. More than 3,000 medical institutions are using Zhende's products in more than 30 provinces and cities in China. Since the start of Zhende in Shaoxing, Zhende Medical has experienced 20 years of development. Zhende Medical adheres to the corporate spirit of "responsibility, learning, dedication and integrity", based on the development of its main business, builds core competitiveness, and takes "brand, innovation, and professionalism" In order to achieve business philosophy, we will seize the historical opportunities of the development of China's disposable medical consumables market demand, accelerate industrial integration and product research and development and innovation, increase R&D investment, market channel construction and talent construction, realize the strategic transformation of the enterprise industry, and improve the core competitiveness of the enterprise. Zhende Medical is gathering more strength to promote the sustainable development of the company through technological innovation and business model innovation.
Medline is a leading healthcare company providing medical supplies and equipment, including high-quality commode chairs for patients and caregivers.
Medline Industries, Inc.
Medline is a leading healthcare company providing medical supplies and equipment, including high-quality commode chairs for patients and caregivers.
McKesson is a global leader in healthcare supply chain management, offering a variety of medical products, including commode chairs.
McKesson Corporation
McKesson is a global leader in healthcare supply chain management, offering a variety of medical products, including commode chairs.
Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.
Cardinal Health, Inc.
Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, pharmacies, and laboratories.
Becton, Dickinson and Company
BD is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents.
Becton, Dickinson and Company
BD is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents.
A multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Johnson & Johnson
A multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Curad is a trusted brand in the healthcare industry, providing a variety of first-aid products, including bandages, antiseptics, and wound care items.
Medline Industries
Curad is a trusted brand in the healthcare industry, providing a variety of first-aid products, including bandages, antiseptics, and wound care items.
Smith & Nephew is a global medical technology company providing innovative bone-cutting tools for orthopedic and trauma surgeries.
Smith & Nephew plc
Smith & Nephew is a global medical technology company providing innovative bone-cutting tools for orthopedic and trauma surgeries.
Medline Plus is a product line from Medline Industries that includes cotton balls among other healthcare products.
Medline Industries
Medline Plus is a product line from Medline Industries that includes cotton balls among other healthcare products.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
